Author:
Kim Juhyun,Coss Christopher C.,Dalton James T.
Publisher
Springer Science and Business Media LLC
Subject
Organic Chemistry,Drug Discovery,Molecular Medicine
Reference23 articles.
1. Banker, M.J., T.H. Clark, and J.A. Williams. 2003. Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding. Journal of Pharmaceutical Sciences 92: 967–974.
2. Behre, H.M., K. Abshagen, M. Oettel, D. Hubler, and E. Nieschlag. 1999a. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: Phase I studies. European Journal of Endocrinology 140: 414–419.
3. Behre, H.M., S. von Eckardstein, S. Kliesch, and E. Nieschlag. 1999b. Long-term substitution therapy of hypogonadal men with transscrotal testosterone over 7–10 years. Clin Endocrinol (Oxf) 50: 629–635.
4. Behre, H.M., C. Wang, D.J. Handelsman, and E. Nieschlag. 2004. Pharmacology of testosterone preparations. In Testosterone, ed. E. Nieschlag, and H.M. Behre, 405–444. Cambridge: Cambridge University Press.
5. Bhasin, S., R.S. Swerdloff, B. Steiner, M.A. Peterson, T. Meridores, M. Galmirini, M.R. Pandian, R. Goldberg, and N. Berman. 1992. A biodegradable testosterone microcapsule formulation provides uniform eugonadal levels of testosterone for 10–11 weeks in hypogonadal men. Journal of Clinical Endocrinology and Metabolism 74: 75–83.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献